Crossmark

Soluble urokinase plasminogen activator receptor (suPAR) is a potential biomarker of stage III-IV, grade C periodontitis through the impact of post-radiotherapy on head and neck cancer patients

Crossref DOI link: https://doi.org/10.1186/s12903-024-04801-w

Published Online: 2024-09-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-Kubaisi, Ahmed A. https://orcid.org/0009-0002-6874-6346
Ghazi, Maysam Abdulrahman

Majeed, Nisreen Salah

Aldelaimi, Ekram R.

Enezei, Hamid H.
License Information

Text and Data Mining valid from 2024-09-27

Version of Record valid from 2024-09-27
More Information

Article History

Received: 27 January 2024

Accepted: 23 August 2024

First Online: 27 September 2024

Declarations

:

: All participants understood the nature of the research project and provided written informed consent to participate in this study. Permission for this study was obtained from Scientific Research Evaluation Ethical Committee of Ministry of Health, Al-Anbar Directorate of Health, Iraq (NO:2022057, Date: Aug., 22, 2022).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below